Jointstrong Intervention for Juvenile Arthritis
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
If your child is eligible and decides to participate in this study, this participation will last approximately eight weeks. Please refer to the table at the end of this consent form.
Your child's participation in this study will involve the completion of daily questionnaires during a one-week baseline period and a one-week follow-up period. These questionnaires will contain various questions about your child's arthritis and his/her ability to do various activities. The questionnaires will take approximately 15-30 minutes each week to complete.
Your child will be randomly assigned to complete one of two CD-ROM programs. One of the CD-ROM programs is a "control" program that contains educational information about arthritis and medical treatments and the other is the "treatment" program and contains the same educational information as the control program plus information on behavioral strategies for controlling symptoms of arthritis. Your child's participation in this study will involve working through one of these CD-ROM programs over a one-month period. Your child will also continue to receive medical treatment from the rheumatologist treating your child for arthritis. The CD-ROM programs involve working through developmentally appropriate lessons on the nature of arthritis and how to treat it. The CD-ROM programs are divided into weekly "modules" and are designed to be completed within four weeks. Lessons take an average of 15 minutes to complete (plus "homework"), and there is an average of 4 lessons to complete each week.
Your participation in this study will involve the completion of questionnaires and helping your child understand any parts of the study that he or she does not understand.
Typ studie
Zápis (Aktuální)
Fáze
- Nelze použít
Kontakty a umístění
Studijní místa
-
-
Kansas
-
Kansas City, Kansas, Spojené státy, 66160
- University of Kansas Medical Center
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria. Patients recruited for this study will meet the following inclusion criteria: (a) are 8-12 years of age; (b) have a diagnosis of JA by a pediatric rheumatologist using established criteria, and (c) have JA-related (joint) pain occurring on an average of at least once per week by patient report [9]. Participants in the age range 8-12 years will be recruited because the intervention will be tailored to children (future studies will involve creating and testing a version of Jointstrong for adolescents). Although access to a home computer with a CD-ROM drive is required for the study, this will not be an inclusion criterion, and we expect the lack of access will be rare, as our pilot data on 37 children with headaches found that only 2% (1 child) did not have adequate home computer access [15]. So as not to exclude the few children without access who otherwise qualify for the study, we will lend laptop computers to these children. All children meeting symptom inclusion criteria will therefore be able to use the adjunctive CD-ROM programs in a home setting.
Exclusion Criteria. Patients will be excluded from the study if (a) their parents or rheumatologist report they have been diagnosed with a mental health condition or they are receiving concurrent psychotherapy; or (b) their 14-day baseline pain diaries indicate they have pain, on average, less than one day per week; or (c) they do not speak English.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: CD-ROM-treatment
|
Treatment Group will continue to follow their treating rheumatologist's recommendations and prescriptions.
The program will contain information on the multiple components of pain (the "pain puzzle") as a treatment rationale and will then teach children to use cognitive-behavioral techniques for pain management.
The information will be presented via visual displays, narration, and interactive menus.
Children will be able to navigate through the different lessons at their own pace and will be required to take simple quizzes to assess their learning.
Various passwords and homework assignments are embedded within the program to ensure that children are going through the material.
|
|
Aktivní komparátor: Wait-list Control Group
|
Children in the control group will continue to follow recommendations and prescriptions by their treating rheumatologist.
After an 8-week wait-list control condition that involves measurement phases identical to those of the Jointstrong Treatment Group but no Jointstrong treatment, the children in the control group will enter the Jointstrong program and will then have the same immediate post-treatment measures that the Treatment Group received.
The Control Group will not, however, have the Treatment Group's 12-week follow-up phase.
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Pain
Časové okno: weekly for 12 weeks
|
Pain intensity on a 0 to 10 visual analog scale with 0 being no pain and 10 being worst possible pain.
|
weekly for 12 weeks
|
Sekundární výstupní opatření
Měření výsledku |
Časové okno |
|---|---|
|
Mood and Stress
Časové okno: weekly for 12 weeks
|
weekly for 12 weeks
|
|
Quality of Life
Časové okno: weekly for 12 weeks
|
weekly for 12 weeks
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Michael Rapoff, Ph D, University of Kansas Medical Center
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia
Primární dokončení (Aktuální)
Dokončení studie (Aktuální)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhad)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Odhad)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- 11154 (DAIDS ES Registry Number)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .
Klinické studie na CD-ROM
-
Michael Rapoff, Ph.D.National Institute of Neurological Disorders and Stroke (NINDS)Dokončeno
-
Centers for Disease Control and PreventionUniversity of Colorado, DenverDokončeno
-
Duke UniversityNational Cancer Institute (NCI)DokončenoNespecifikovaný dospělý solidní nádor, specifický pro protokolSpojené státy
-
Fox Chase Cancer CenterNational Cancer Institute (NCI)DokončenoKolorektální karcinom | Dědičná nepolypózní rakovina tlustého střevaSpojené státy
-
Duzce UniversityDokončeno
-
Universitaire Ziekenhuizen KU LeuvenNábor
-
Cairo UniversityNábor
-
Necmettin Erbakan UniversityZatím nenabíráme
-
Golden Jubilee National HospitalNeznámý
-
Medical College of WisconsinChildren's Hospital of PhiladelphiaDokončenoMaligní onemocnění (tj. leukémie, MDS, lymfom) | Nezhoubná onemocnění (tj. syndromy selhání kostní dřeně)Spojené státy